- Home
- DCTH vs ANGO Comparison
DCTH vs ANGO Comparison
Compare DCTH & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- ANGO
- Stock Information
- Founded
- DCTH 1988
- ANGO 1988
- Country
- DCTH United States
- ANGO United States
- Employees
- DCTH N/A
- ANGO N/A
- Industry
- DCTH Medical/Dental Instruments
- ANGO Medical/Dental Instruments
- Sector
- DCTH Health Care
- ANGO Health Care
- Exchange
- DCTH Nasdaq
- ANGO Nasdaq
- Market Cap
- DCTH 388.3M
- ANGO 400.8M
- IPO Year
- DCTH N/A
- ANGO 2004
- Fundamental
- Price
- DCTH $11.75
- ANGO $11.01
- Analyst Decision
- DCTH Strong Buy
- ANGO Strong Buy
- Analyst Count
- DCTH 4
- ANGO 3
- Target Price
- DCTH $24.50
- ANGO $19.00
- AVG Volume (30 Days)
- DCTH 497.8K
- ANGO 376.4K
- Earning Date
- DCTH 11-07-2025
- ANGO 10-02-2025
- Dividend Yield
- DCTH N/A
- ANGO N/A
- EPS Growth
- DCTH N/A
- ANGO N/A
- EPS
- DCTH 0.06
- ANGO N/A
- Revenue
- DCTH $70,240,000.00
- ANGO $292,498,000.00
- Revenue This Year
- DCTH $159.22
- ANGO $7.13
- Revenue Next Year
- DCTH $42.78
- ANGO $6.28
- P/E Ratio
- DCTH $211.26
- ANGO N/A
- Revenue Growth
- DCTH 491.35
- ANGO N/A
- 52 Week Low
- DCTH $8.08
- ANGO $5.83
- 52 Week High
- DCTH $18.23
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- DCTH 59.13
- ANGO 69.66
- Support Level
- DCTH $10.61
- ANGO $10.34
- Resistance Level
- DCTH $11.38
- ANGO $11.04
- Average True Range (ATR)
- DCTH 0.49
- ANGO 0.34
- MACD
- DCTH 0.06
- ANGO -0.01
- Stochastic Oscillator
- DCTH 79.61
- ANGO 89.91
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.